Skip to main content
ASTH logo

ASTH · Astrana Health, Inc. · Documents

Track ASTH — free
Market Cap
$1.61B
Shares
55.80M
Volume · Nov 20 441.03K Avg daily vol (3M) 377.55K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023
Nov 9
Quarterly report 10-Q FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $348.17M ▲ 9.8% Net income $22.06M ▼ 4.9% Diluted EPS $0.47 ▼ 6.0%
Aug 9
Quarterly report 10-Q/A FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $337.24M ▲ 28.1% Net income $13.13M ▼ 4.6% Diluted EPS $0.28 ▼ 6.7%
Aug 9
Annual report 10-K/A FY2022, ended Dec 31
Annual report for FY2022
Revenue $1.14B ▲ 47.8% Net income $45.17M ▼ 34.5% Diluted EPS $0.99 ▼ 34.9%
Aug 9
Quarterly report 10-Q FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $348.21M ▲ 29.1% Net income $13.17M ▲ 10.2% Diluted EPS $0.28 ▲ 7.7%
May 10
Quarterly report 10-Q FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $337.24M ▲ 28.1% Net income $14.62M ▲ 2.5% Diluted EPS $0.31 ▲ unchanged
Mar 1
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $1.14B ▲ 47.8% Net income $49.05M ▼ 33.6% Diluted EPS $1.08 ▼ 33.7%
2022
Nov 7
Quarterly report 10-Q FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $317M ▲ 39.6% Net income $25.99M ▼ 24.2% Diluted EPS $0.56 ▼ 24.3%
Aug 9
Quarterly report 10-Q FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $269.7M ▲ 53.6% Net income $11.4M ▼ 9.9% Diluted EPS $0.25 ▼ 10.7%
May 10
Quarterly report 10-Q FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $263.26M ▲ 49.5% Net income $14.26M ▲ 8.5% Diluted EPS $0.31 ▲ 3.3%
Showing 101–150 of 212 documents
Key facts CIK 1083446 CUSIP 03763A207 13F (30d) 218 filings 198 filers Visit website Investor relations